Working to find actionable solutions to the nation's key challenges.

PEPFAR 4.0: Reauthorization & Beyond


WHEN: Tuesday, December 12, 2017 2:00 p.m. to 4:00 p.m. ET

WHERE: Bipartisan Policy Center, 1225 Eye St NW, Suite 1000, Washington, DC, 20005

Share on FacebookTweet about this on TwitterShare on LinkedInPin on PinterestShare on TumblrEmail this to someonePrint this page
Add to Calendar

No program better demonstrates the power of a well-executed global health initiative than the President’s Emergency Plan for AIDS Relief (PEPFAR). It was established by President George W. Bush in 2003 with bipartisan support from Congress. Over the past decade, PEPFAR has not only reduced the mortality and morbidity from HIV/AIDS, but may have had key secondary effects that enhance U.S. national security interests.

Next year, PEPFAR’s funding will come up for reauthorization before Congress. On December 12 BPC hosted a discussion on the impact of PEPFAR, the importance of continuing U.S. investments in global health, and how these investments can be one of the country’s most effective diplomatic tools.



Senator Tom Daschle
Co-Founder, BPC
Former U.S. Senate Majority Leader

Senator Johnny Isakson (R-GA)

Ambassador Deborah Birx, M.D.
U.S. Global AIDS Coordinator & U.S. Special Representative for Global Health Diplomacy

Chris Collins
President, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria

William R. Steiger
Chief of Staff, The U.S. Agency for International Development

Dr. Nomonde Nolutshungu
Health Attaché (Minister Counsellor), South African Embassy

Clifford Samuel
Senior Vice President of Access Operations and Emerging Markets, Gilead Sciences, Inc.

Dr. Anand Parekh
Chief Medical Advisor, BPC

Jennifer Kates
Vice President and Director of Global Health & HIV Policy, Kaiser Family Foundation